At Wyeth, we are proud of the innovative health care products that we bring to the world. Our pharmaceutical research and development, some of which is conducted through global strategic alliances, have resulted in a research pipeline that is among the most robust in the industry. R&D Directions magazine has recognized Wyeth's pipeline as one of the top 10 in our industry—in 2005 as "the Pipeline to Watch." In 2006, with a balanced focus in traditional small molecules, vaccines, and biopharmaceuticals, we expect our pipeline to continue its excellent growth.
Please click here to visit wyeth.com and view our product pipeline.